LEVODOPA/CARBIDOPA/ENTACAPONA MYLAN 100mg/25mg/200mg film-coated tablets GENERICS
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
letter L · page 28
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + carbidopa + entacapone Indicated for: Parkinson's disease
N04BA03 Nervous system | Dopaminergic agents | Dopa and dopa derivatives